Quick Answer
Minerva Neurosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $82.30 million for the year ending 2025.
- Minerva Neurosciences, Inc. showed an increase of +285.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $1.48 million | Q3 2013: $1.10 million | Q1 2014: $2.14 million | Q2 2014: $480.0 thousand | Q3 2014: $23.64 million | Q1 2015: $52.20 million | Q2 2015: $21.74 million | Q3 2015: $16.84 million | Q1 2016: $34.82 million | Q2 2016: $88.67 million | Q3 2016: $91.85 million | Q1 2017: $68.89 million | Q2 2017: $50.19 million | Q3 2017: $36.25 million | Q1 2018: $45.13 million | Q2 2018: $68.69 million | Q3 2018: $87.30 million | Q1 2019: $30.61 million | Q2 2019: $27.84 million | Q3 2019: $37.91 million | Q1 2020: $30.04 million | Q2 2020: $32.25 million | Q3 2020: $32.52 million | Q1 2021: $80.14 million | Q2 2021: $74.21 million | Q3 2021: $65.59 million | Q1 2022: $54.95 million | Q2 2022: $49.75 million | Q3 2022: $40.22 million | Q1 2023: $35.98 million | Q2 2023: $51.80 million | Q3 2023: $46.90 million | Q1 2024: $34.82 million | Q2 2024: $30.88 million | Q3 2024: $26.53 million | Q1 2025: $17.29 million | Q2 2025: $15.25 million | Q3 2025: $12.29 million.
- Over the full 14 years of available data (2012 to 2025), Minerva Neurosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 40,986.4%.
- Historical annual values: Fiscal year 2025: $82.30 million | Fiscal year 2024: $21.36 million | Fiscal year 2023: $40.91 million | Fiscal year 2022: $36.09 million | Fiscal year 2021: $60.76 million | Fiscal year 2020: $25.36 million | Fiscal year 2019: $21.41 million | Fiscal year 2018: $50.23 million | Fiscal year 2017: $26.05 million | Fiscal year 2016: $82.98 million | Fiscal year 2015: $14.28 million | Fiscal year 2014: $18.55 million | Fiscal year 2013: $1.82 million | Fiscal year 2012: $200.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: